240 related articles for article (PubMed ID: 26954807)
1. Molecular predictive and prognostic factors in ependymoma.
Benson R; Mallick S; Julka PK; Rath GK
Neurol India; 2016; 64(2):279-86. PubMed ID: 26954807
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
3. Utility of copy number variants in the classification of intracranial ependymoma.
Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous supratentorial anaplastic and infratentorial low grade ependymomas with distinct genetic profiles.
Wang JL; Hong CS; Henderson EY; Salma A; Heerema NA; Ray-Chaudhury A; Elder JB
J Neurosurg Sci; 2018 Aug; 62(4):526-529. PubMed ID: 29938482
[No Abstract] [Full Text] [Related]
6. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic study of 33 ependymomas.
Vagner-Capodano AM; Zattara-Cannoni H; Gambarelli D; Figarella-Branger D; Lena G; Dufour H; Grisoli F; Choux M
Cancer Genet Cytogenet; 1999 Dec; 115(2):96-9. PubMed ID: 10598140
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups.
Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J
J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma.
Shu C; Wang Q; Yan X; Wang J
Clin Transl Oncol; 2018 Nov; 20(11):1439-1447. PubMed ID: 29704232
[TBL] [Abstract][Full Text] [Related]
11. Intracranial ependymomas: molecular insights and translation to treatment.
Lester A; McDonald KL
Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
[TBL] [Abstract][Full Text] [Related]
12. A prognostic gene expression signature in infratentorial ependymoma.
Wani K; Armstrong TS; Vera-Bolanos E; Raghunathan A; Ellison D; Gilbertson R; Vaillant B; Goldman S; Packer RJ; Fouladi M; Pollack I; Mikkelsen T; Prados M; Omuro A; Soffietti R; Ledoux A; Wilson C; Long L; Gilbert MR; Aldape K;
Acta Neuropathol; 2012 May; 123(5):727-38. PubMed ID: 22322993
[TBL] [Abstract][Full Text] [Related]
13. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
[TBL] [Abstract][Full Text] [Related]
14. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
[TBL] [Abstract][Full Text] [Related]
15. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
Dorfer C; Tonn J; Rutka JT
Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis.
Tominaga T; Kayama T; Kumabe T; Sonoda Y; Yoshimoto T
Acta Neurochir (Wien); 1995; 135(3-4):163-70. PubMed ID: 8748809
[TBL] [Abstract][Full Text] [Related]
18. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
[TBL] [Abstract][Full Text] [Related]
19. Supratentorial "vascular" variant of ependymoma: a lesser known morphologic variant and a diagnostic pitfall.
Gupta K; Chandrasekaran M; Garg R; Salunke P
Childs Nerv Syst; 2016 Sep; 32(9):1569-71. PubMed ID: 27392446
[No Abstract] [Full Text] [Related]
20. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas.
Jaing TH; Wang HS; Tsay PK; Tseng CK; Jung SM; Lin KL; Lui TN
J Neurooncol; 2004 Jul; 68(3):255-61. PubMed ID: 15332330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
